药明生物已经按全切割计提了,这8年时间一给,迎来了超级大转机,8年的时间,兔子和老鹰之间都够亲亲合合好几回了。。这个法案已经鸡肋化。。
With Congress on track to pass legislation based on the Biosecure Act in December, the biopharma industry is scrambling to collect evidence about the impacts of a forced decoupling from Chinese contract development and manufacturing organizations and to use the information to convince lawmakers to modify the bill.
A May 15 House Oversight and Accountability Committee hearing that will consider proposals to modify the Biosecure Act (H.R. 7085) will provide an early readout on the efficacy of the industry’s lobbying on the bill...
不至于太差